Log In
Print this Print this

PSA-Oxyntomodulin (Oxyntolong)

  Manage Alerts
Collapse Summary General Information
Company Pharmsynthez JSC
DescriptionPolysialylated formulation of oxyntomodulin, a dual glucagon-like peptide-1 (GLP-1) and glucagon receptor (GCGR) agonist, using Xenetic's PolyXen delivery technology
Molecular Target Glucagon-like peptide-1 receptor (GLP-1R) (GLP1R) ; Glucagon receptor (GCGR)
Mechanism of ActionGlucagon-like peptide-1 (GLP-1) receptor agonist; Glucagon receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes and obesity
Regulatory Designation
PartnerXenetic Biosciences Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today